ATR as reported
AptarGroup, Inc. reported $3.93B of revenue over the trailing twelve months, +8.9% on the year before. 11 reported series are charted on this page, each one as filed.
$3.93B
Revenue, trailing twelve months · to Q2 2026 · +8.9% against the twelve months before
- Net Income
- $363M
Net Income · −7.2% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $310M
Free Cash Flow · −15% year on year · trailing twelve months to Q2 2026
- Op Margin
- 12%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.93B | +8.9% | Q2 2026 |
| Net Income | $363M | −7.2% | Q2 2026 |
| EPS | $5.54 | −4.5% | Q2 2026 |
| Gross Margin | 36% | n/a | Q2 2026 |
| Op Margin | 12% | n/a | Q2 2026 |
| Net Margin | 9.2% | n/a | Q2 2026 |
| ROE | 15% | n/a | Q2 2026 |
| ROA | 7.6% | n/a | Q2 2026 |
| ROIC | 10% | n/a | Q2 2026 |
| Free Cash Flow | $310M | −15% | Q2 2026 |
| P/E | 24.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
AptarGroup, Inc. (ATR) - Revenue & ProfitRevenue & ProfitAptarGroup, Inc. (ATR)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #21 of 27 by Smart Score